Clinical inertia in the management of patients with post-COVID 19 neurological syndrome: a problem without current evidence

Authors

  • Ivan David Lozada-Martinez Universidad de Cartagena
  • María Isabel Hernández-González Universidad del Norte
  • Cindy Vanessa Villarreal-Montenegro Universidad cooperativa de Colombia
  • José Wdroo Motta-Hernández Universidad de Ciencias Aplicadas y Ambientales
  • Nury Paola Arias-Leon Fundación Universitaria San Martin
  • Luis Rafael Moscote-Salazar Latin American Council of Neurocritical Care

DOI:

https://doi.org/10.31157/an.v29i2.406

Keywords:

Clinical inertia, post-COVID 19 neurological syndrome, post-COVID 19 syndrome, COVID-19, Neurological Disease

Abstract

Not applicable

References

Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001; 135(9):825-34. doi: 10.7326/0003-4819-135-9-200111060-00012 DOI: https://doi.org/10.7326/0003-4819-135-9-200111060-00012

Camargo-Martínez W, Lozada-Martínez I, Escobar-Collazos A, Navarro-Coronado A, Moscote-Salazar L, Pacheco-Hernández A, et al. Post-COVID 19 neurological syndrome: Implications for sequelae's treatment. J Clin Neurosci. 2021; 88:219-225. doi: 10.1016/j.jocn.2021.04.001 DOI: https://doi.org/10.1016/j.jocn.2021.04.001

Gavrilova N, Soprun L, Lukashenko M, Ryabkova V, Fedotkina TV, Churilov LP, et al. New Clinical Phenotype of the Post-Covid Syndrome: Fibromyalgia and Joint Hypermobility Condition. Pathophysiology. 2022; 29(1):24-29. doi: 10.3390/pathophysiology29010003 DOI: https://doi.org/10.3390/pathophysiology29010003

Lozada-Martínez ID, Díaz-Castillo OJ, Pearson-Arrieta AC, Galeano-Buelvas A, Moscote-Salazar LR. Post-COVID 19 neurological syndrome: A new risk factor that modifies the prognosis of patients with dementia. Alzheimers Dement. 2021; 10.1002/alz.12459. doi: 10.1002/alz.12459 DOI: https://doi.org/10.1002/alz.12459

Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, et al. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci. 2021; 71(11):2192-2209. doi: 10.1007/s12031-020-01767-6 DOI: https://doi.org/10.1007/s12031-020-01767-6

Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022; 434:120162. doi: 10.1016/j.jns.2022.120162 DOI: https://doi.org/10.1016/j.jns.2022.120162

Yong SJ. Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis. ACS Chem Neurosci. 2021; 12(4):573-580. doi: 10.1021/acschemneuro.0c00793 DOI: https://doi.org/10.1021/acschemneuro.0c00793

Frontera JA, Yang D, Lewis A, Patel P, Medicherla C, Arena V, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. 2021; 426:117486. doi: 10.1016/j.jns.2021.117486 DOI: https://doi.org/10.1016/j.jns.2021.117486

National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP). COVID-19 rapid guideline: managing the long-term effects of COVID-19 [Internet]. [Consulted 11 Apr 2022]. Available in: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742

Vu T, McGill SC. An Overview of Post–COVID-19 Condition (Long COVID). Canadian Journal of Health Technologies. 2021; 1(9):1-31. doi: 10.51731/cjht.2021.160 DOI: https://doi.org/10.51731/cjht.2021.160

Additional Files

Published

2022-10-20

How to Cite

Lozada-Martinez, I. D., Hernández-González, M. I., Villarreal-Montenegro, C. V., Motta-Hernández, J. W., Arias-Leon, N. P., & Moscote-Salazar, L. R. (2022). Clinical inertia in the management of patients with post-COVID 19 neurological syndrome: a problem without current evidence. Archivos De Neurociencias, 29(2). https://doi.org/10.31157/an.v29i2.406

Issue

Vol. 29 No. 2 (2024)

Section

Editorial

License

Copyright (c) 2022 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.

January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.

January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Most read articles by the same author(s)